Cargando…
Mitochondrial DNA deletions in muscle satellite cells: implications for therapies
Progressive myopathy is a major clinical feature of patients with mitochondrial DNA (mtDNA) disease. There is limited treatment available for these patients although exercise and other approaches to activate muscle stem cells (satellite cells) have been proposed. The majority of mtDNA defects are he...
Autores principales: | Spendiff, Sally, Reza, Mojgan, Murphy, Julie L., Gorman, Grainne, Blakely, Emma L., Taylor, Robert W., Horvath, Rita, Campbell, Georgia, Newman, Jane, Lochmüller, Hanns, Turnbull, Doug M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3820134/ https://www.ncbi.nlm.nih.gov/pubmed/23847047 http://dx.doi.org/10.1093/hmg/ddt327 |
Ejemplares similares
-
Mitochondrial Mutations Can Alter Neuromuscular Transmission in Congenital Myasthenic Syndrome and Mitochondrial Disease
por: O’Connor, Kaela, et al.
Publicado: (2023) -
Disease progression in patients with single, large-scale mitochondrial DNA deletions
por: Grady, John P., et al.
Publicado: (2014) -
Pathological mechanisms underlying single large‐scale mitochondrial DNA deletions
por: Rocha, Mariana C., et al.
Publicado: (2018) -
Neuromuscular Junction Changes in a Mouse Model of Charcot-Marie-Tooth Disease Type 4C
por: Cipriani, Silvia, et al.
Publicado: (2018) -
Ultrasensitive deletion detection links mitochondrial DNA replication, disease, and aging
por: Lujan, Scott A., et al.
Publicado: (2020)